BPI Labs joins Empower Pharmacy in challenging Eli Lilly’s tirzepatide patent over GLP-1 exclusivity
BPI Labs has announced its collaboration with Empower Pharmacy to challenge Eli Lilly's patent on tirzepatide. Read More »
BPI Labs has announced its collaboration with Empower Pharmacy to challenge Eli Lilly's patent on tirzepatide. Read More »
The National Community Pharmacists Association (NCPA) has voiced strong opposition to a reported proposal that would allow pharmacy benefit managers (PBMs) to self-regulate. Read More »
The Nurses United for Healthcare Integrity (NUHI) has raised concerns about the exploitation of the 340B Drug Pricing Program by hospitals. Read More »
The South Dakota Health Link will hold its 2025 Fall Forum through a series of three virtual sessions. Read More »
The Virginia Department of Health has announced a new statewide standing order signed by State Health Commissioner Karen Shelton, MD, on September 10. Read More »
The National Community Pharmacists Association (NCPA) has announced a series of upcoming events and educational opportunities for pharmacists and pharmacy teams. Read More »
The National Community Pharmacists Association (NCPA) has responded to the Federal Trade Commission’s decision to appoint Emma Mittelstaedt Burnham as associate director of health care in the Bureau of Competition. Read More »
The National Community Pharmacists Association (NCPA) has sent a letter to Congressional leaders, representing a coalition of 134 organizations that include patient groups, health care providers, employers, business groups, and union workers. Read More »
Nearly one in five independent pharmacists say they will not stock drugs included in the Medicare Drug Price Negotiation Program, and another 67 percent report they may also choose not to participate. Read More »
Dutch Rojas, founder of ReKlaim Health, said that the 340B program has deviated from its original mission to assist low-income patients and instead allows health systems to profit from drug pricing arbitrage. Read More »
Bret Jackson, President and CEO of the Economic Alliance for Michigan, has raised concerns about hospitals' use of 340B revenue. Read More »
Ken Paxton, the Attorney General for Texas, has accused Eli Lilly of using illegal kickbacks to influence prescriptions of its drugs for profit, potentially harming taxpayers and public health. Read More »
Jung Hoon Son, M.D., Head of Clinical Informatics at Trellis Health, has called for healthcare reform efforts to focus on pharmacy benefit managers (PBMs), 340B program abuse, hospital inefficiencies, and targeted fraud rather than placing broad... Read More »
The Cannabis Regulatory Agency (CRA) and the Bay Mills Indian Community (BMIC) have signed Michigan's first tribal-state cannabis compact, enabling BMIC to participate directly in the state’s licensed adult-use cannabis market. Read More »
South Dakota has avoided a widespread measles outbreak, with no new cases reported in the past four weeks. Read More »
The National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), and the Tennessee Pharmacists Association (TPA) have filed a joint amicus brief in federal court supporting Tennessee’s 2021 law regulating... Read More »
The National Community Pharmacists Association (NCPA) has announced a series of upcoming events aimed at pharmacists and pharmacy team members. Read More »
The South Dakota Department of Agriculture and Natural Resources (DANR) and the Department of Health (DOH) have issued an air quality alert for South Dakota. Read More »
Shaun Noorian, CEO of Empower Pharmacy, said that recent findings by the U.S. Food and Drug Administration (FDA) indicate that efforts by the pharmaceutical industry to discredit compounding pharmacies were not rooted in safety concerns. Read More »
The National Community Pharmacists Association (NCPA) has expressed its approval for a new bill introduced by Senate Majority Leader John Thune and Senator Mark Warner. Read More »